Align real estate to accelerate value
Leverage real estate to realize value in life sciences mergers and acquisitions.
Download our M&A overview and schedule your free diagnostic conversation.
Mergers and acquisitions can accelerate innovation, advance operations and bolster product portfolios. They can also bring risk, uncertainty and implementation challenges. But one key piece can help everything else click into place. That piece is real estate. Our team expertly aligns real estate and laboratory facilities to accelerate the value of life sciences M&A activity.
Early input for better outcomes
CBRE believes organizations realize the best outcomes when they include real estate early in the M&A process. With deep roots in the life sciences industry, CBRE tailors data-driven insights and creative strategies to help our biopharma clients:
Accelerate value realization across portfolios
- Capital liabilities, consolidations and disposals
- Strategic site and location analytics
Create operational efficiency and minimize disruption
- Occupancy and operational planning
- Short- and long-term portfolio impacts
- Lab/GMP project and move management services
Drive cost containment and mitigate risk
- Total cost of ownership calculation
- Contractual expense assessment
- Portfolio flexibility and forecasting
Promote the shared brand, integrate culture and manage change
- Employee experience and physical space
- Company identity and talent strategies
- Digital ecosystem alignment